A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients

Posttransplantation cytomegalovirus (CMV) infection remains a significant cause of morbidity in kidney transplant recipients. We performed a randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for CMV prophylaxis in a group of renal allograft recipients considered at hi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 1998-12, Vol.66 (12), p.1682-1688
Hauptverfasser:	FLECHNER, S. M, AVERY, R. K, FISHER, R, MASTROIANNI, B. A, PAPAJCIK, D. A, O'MALLEY, K. J, GOORMASTIC, M, GOLDFARB, D. A, MODLIN, C. S, NOVICK, A. C
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Acyclovir - administration & dosage Acyclovir - therapeutic use Administration, Oral Adult Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - therapeutic use Biological and medical sciences Cytomegalovirus Infections - prevention & control Female Ganciclovir - administration & dosage Ganciclovir - therapeutic use Graft Rejection Humans Immunization, Passive Immunoglobulins Immunoglobulins, Intravenous Kidney Transplantation - adverse effects Male Medical sciences Middle Aged Pharmacology. Drug treatments Prospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!